4516 Stock Overview
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Rewards
Risk Analysis
Nippon Shinyaku Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥3,226.00 |
| 52 Week High | JP¥6,784.00 |
| 52 Week Low | JP¥2,694.00 |
| Beta | -0.13 |
| 11 Month Change | 15.67% |
| 3 Month Change | -27.83% |
| 1 Year Change | -45.08% |
| 33 Year Change | -63.13% |
| 5 Year Change | -60.12% |
| Change since IPO | 204.82% |
Recent News & Updates
Recent updates
Why Investors Shouldn't Be Surprised By Nippon Shinyaku Co., Ltd.'s (TSE:4516) 29% Share Price Plunge
Jun 04
Many Still Looking Away From Nippon Shinyaku Co., Ltd. (TSE:4516)
Apr 19Nippon Shinyaku (TSE:4516) Is Due To Pay A Dividend Of ¥62.00
Mar 18Nippon Shinyaku (TSE:4516) Will Pay A Dividend Of ¥62.00
Feb 26Shareholder Returns
| 4516 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 3.0% | 5.3% | 2.4% |
| 1Y | -45.1% | 6.2% | 19.2% |
Return vs Industry: 4516 underperformed the JP Pharmaceuticals industry which returned 6.2% over the past year.
Return vs Market: 4516 underperformed the JP Market which returned 19.2% over the past year.
Price Volatility
| 4516 volatility | |
|---|---|
| 4516 Average Weekly Movement | 7.4% |
| Pharmaceuticals Industry Average Movement | 3.9% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in JP Market | 7.4% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 4516's share price has been volatile over the past 3 months.
Volatility Over Time: 4516's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1911 | 2,186 | Toru Nakai | www.nippon-shinyaku.co.jp |
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases.
Nippon Shinyaku Co., Ltd. Fundamentals Summary
| 4516 fundamental statistics | |
|---|---|
| Market cap | JP¥217.28b |
| Earnings (TTM) | JP¥25.85b |
| Revenue (TTM) | JP¥148.26b |
8.4x
P/E Ratio1.5x
P/S RatioIs 4516 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4516 income statement (TTM) | |
|---|---|
| Revenue | JP¥148.26b |
| Cost of Revenue | JP¥50.23b |
| Gross Profit | JP¥98.02b |
| Other Expenses | JP¥72.17b |
| Earnings | JP¥25.85b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 383.82 |
| Gross Margin | 66.12% |
| Net Profit Margin | 17.44% |
| Debt/Equity Ratio | 0% |
How did 4516 perform over the long term?
See historical performance and comparison